ZA200700483B - Process for the preparation 2-substituted-derivatives of estrone and estradiol - Google Patents

Process for the preparation 2-substituted-derivatives of estrone and estradiol

Info

Publication number
ZA200700483B
ZA200700483B ZA200700483A ZA200700483A ZA200700483B ZA 200700483 B ZA200700483 B ZA 200700483B ZA 200700483 A ZA200700483 A ZA 200700483A ZA 200700483 A ZA200700483 A ZA 200700483A ZA 200700483 B ZA200700483 B ZA 200700483B
Authority
ZA
South Africa
Prior art keywords
estrone
estradiol
derivatives
substituted
preparation
Prior art date
Application number
ZA200700483A
Other languages
English (en)
Inventor
Stoelwinder Johannes
Nicolaas Elisabeth Cornelis Moers
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of ZA200700483B publication Critical patent/ZA200700483B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200700483A 2004-08-04 2007-01-16 Process for the preparation 2-substituted-derivatives of estrone and estradiol ZA200700483B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103742 2004-08-04

Publications (1)

Publication Number Publication Date
ZA200700483B true ZA200700483B (en) 2008-09-25

Family

ID=34929415

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700483A ZA200700483B (en) 2004-08-04 2007-01-16 Process for the preparation 2-substituted-derivatives of estrone and estradiol

Country Status (20)

Country Link
US (2) US7910756B2 (de)
EP (1) EP1776378B1 (de)
JP (1) JP5075626B2 (de)
KR (1) KR20070040386A (de)
CN (1) CN1993376A (de)
AR (1) AR050195A1 (de)
AT (1) ATE447580T1 (de)
AU (1) AU2005268768B2 (de)
BR (1) BRPI0514096A (de)
CA (1) CA2573133C (de)
DE (1) DE602005017500D1 (de)
EC (1) ECSP077228A (de)
ES (1) ES2334244T3 (de)
IL (1) IL180381A0 (de)
MX (1) MX2007001340A (de)
NO (1) NO20070747L (de)
RU (1) RU2007107914A (de)
TW (1) TW200611909A (de)
WO (1) WO2006013196A1 (de)
ZA (1) ZA200700483B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300376B6 (cs) 2008-05-05 2009-05-06 Prírodovedecká Fakulta Uk Ligandy estrogenových receptoru alfa a beta, zpusob jejich prípravy a farmaceutické prostredky, které je obsahují
WO2012020417A1 (en) 2010-08-10 2012-02-16 Reliance Life Sciences Pvt. Ltd. Process for the preparation of estradiol and its derivatives
ES2671238T3 (es) * 2011-08-12 2018-06-05 Siemens Healthcare Diagnostics Inc. Detección de esteroides sexuales
CN104592339A (zh) * 2014-12-30 2015-05-06 湖南新合新生物医药有限公司 雌甾-4,9-二烯-3,17-二酮的制备方法
CN104497088B (zh) * 2014-12-30 2016-08-24 湖南新合新生物医药有限公司 19-去甲-4-雄甾烯-3,17-二酮的制备方法
ITUB20155260A1 (it) * 2015-10-30 2017-04-30 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 17?-idrossi-des-A-androst-9,10-en-5-one
CN108003210A (zh) * 2018-01-24 2018-05-08 四川理工学院 一种雌甾-4,9-二烯-3,17-二酮的制备方法
CN108997463B (zh) * 2018-08-09 2021-05-14 四川理工学院 一种雌甾-4，9-二烯-3，17-二酮制备方法
CN112409434B (zh) * 2020-11-27 2021-10-26 厦门欧瑞捷生物科技有限公司 一种去氢孕酮的合成方法
CN113861158B (zh) * 2021-11-22 2023-02-10 湖南新合新生物医药有限公司 一种合成甲基双烯双酮关键中间体的方法
CN114853802B (zh) * 2022-03-22 2023-11-28 河北康泰药业有限公司 一种谷内酯衍生物及其制备方法、药物组合物和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997488A (en) * 1959-06-20 1961-08-22 Organon 2-methyl-19-nor-steroids
FR1468608A (fr) * 1960-08-04 1967-02-10 Upjohn Co 2-alpha-fluoro stéroïdes de la série de la 19-norandrostène et leur procédé d'obtention
BE616293A (fr) 1961-04-14 1962-10-11 Roussel Uclaf Dérivés de la 19-nor testostérone et procédé de préparation
FR1368721A (fr) * 1961-04-14 1964-08-07 Roussel Uclaf Dérivés de la 19-nor testostérone et procédé de préparation
US3519714A (en) 1966-03-15 1970-07-07 Herchel Smith Synthesis of gona-1,3,5(10)-trienes
US4400524A (en) 1981-07-28 1983-08-23 The Upjohn Company Grignard reagents prepared from 5-halopentan-2-one propylene ketals
DE3208432A1 (de) * 1982-03-09 1983-09-15 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur herstellung von 19-norandrostendion, zwischenprodukt des 19-norandrostendions und verfahren zu seiner herstellung
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
US5998639A (en) 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
IL119649A (en) 1995-11-30 2002-03-10 Akzo Nobel Nv Preparation of Cyclic Kills of History - 3 keto- (5) 10, (-9) 11 steroidadians
US6051726A (en) 1997-03-13 2000-04-18 Pharm-Eco Laboratories, Inc. Synthesis of 2-alkoxyestradiols
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
AU7572600A (en) 1999-08-23 2001-03-19 Entremed, Inc Methods of obtaining 2-methoxyestradiol of high purity
AU8838601A (en) 2000-11-27 2002-06-03 Entremed Inc Antiangiogenic agents

Also Published As

Publication number Publication date
JP2008509109A (ja) 2008-03-27
AU2005268768A1 (en) 2006-02-09
AR050195A1 (es) 2006-10-04
ECSP077228A (es) 2007-03-29
US20110152544A1 (en) 2011-06-23
EP1776378A1 (de) 2007-04-25
US7910756B2 (en) 2011-03-22
NO20070747L (no) 2007-04-23
CA2573133A1 (en) 2006-02-09
US20090012319A1 (en) 2009-01-08
CN1993376A (zh) 2007-07-04
IL180381A0 (en) 2007-06-03
MX2007001340A (es) 2007-03-27
DE602005017500D1 (de) 2009-12-17
RU2007107914A (ru) 2008-09-10
ES2334244T3 (es) 2010-03-08
AU2005268768B2 (en) 2011-10-13
ATE447580T1 (de) 2009-11-15
CA2573133C (en) 2012-07-10
JP5075626B2 (ja) 2012-11-21
KR20070040386A (ko) 2007-04-16
WO2006013196A1 (en) 2006-02-09
BRPI0514096A (pt) 2008-05-27
TW200611909A (en) 2006-04-16
EP1776378B1 (de) 2009-11-04

Similar Documents

Publication Publication Date Title
ZA200700483B (en) Process for the preparation 2-substituted-derivatives of estrone and estradiol
EP1807118B8 (de) Steroidanaloga sowie charakterisierungs- und behandlungsverfahren
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
EP1800685A4 (de) Pharmazeutische steroide saponin-zusammensetzung, ihr herstellungsverfahren und ihre verwendung
EP1828223A4 (de) Neue betulinderivate, deren herstellung und deren verwendung
EP1711186A4 (de) Langsam freigesetzte steroidzusammensetzung
IL178775A0 (en) Pharmaceutical compositions for acute glucocorticoid therapy
HUE050911T2 (hu) Zeolit-béta katalizátor és eljárás az említett katalizátor elõállítására
PL1786744T3 (pl) Sposób opóźniania wiązania gipsu i preparatów gipsowych
ZA200702038B (en) Pharmaceutical composition drospirenone and ethynyle-stradiol
IL176427A0 (en) Di-steroidal prodrugs of ethinyl estradiol
EP1827111A4 (de) Verfahren und zusammensetzung zur reduzierung des faltenauftretens
HK1102395A1 (en) Indene derivatives and process for the preparation thereof
IL182421A0 (en) Process for the preparation of pyrazoles
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
EP1610798A4 (de) Estradiolmetaboliten zur behandlung von lungenhochdruck
GB0406635D0 (en) Process for the preparation of an emulsion
EP1756036A4 (de) Indenderivate und verfahren zu deren herstellung
EP1745000A4 (de) Neue anthrachinone, herstellungsverfahren und verwendung dafür
ZA200704715B (en) Integrated preparation and separation process
ZA200704714B (en) Integrated separation and preparation process
ZA200609685B (en) Pharmaceutical compositions for acute glucocorticoid therapy
EP1825860A4 (de) Panaxatriolsaponinzusammensetzung, verfahren zu ihrer herstellung und anwendung
ZA200704806B (en) Novel betulin derivatives, preparation thereof and use thereof
IL182970A0 (en) Compositions and processes for preparing 13-deoxy-anthracyclines